DK454176A - GALENIC PREPARATIONS - Google Patents

GALENIC PREPARATIONS

Info

Publication number
DK454176A
DK454176A DK454176A DK454176A DK454176A DK 454176 A DK454176 A DK 454176A DK 454176 A DK454176 A DK 454176A DK 454176 A DK454176 A DK 454176A DK 454176 A DK454176 A DK 454176A
Authority
DK
Denmark
Prior art keywords
galenic preparations
galenic
preparations
Prior art date
Application number
DK454176A
Other languages
Danish (da)
Other versions
DK146194B (en
DK146194C (en
Inventor
L Ehrhardt
V Hartmann
L Patt
K H Otto
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Ag filed Critical Sandoz Ag
Publication of DK454176A publication Critical patent/DK454176A/en
Publication of DK146194B publication Critical patent/DK146194B/en
Application granted granted Critical
Publication of DK146194C publication Critical patent/DK146194C/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/48—Ergoline derivatives, e.g. lysergic acid, ergotamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Neurosurgery (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK454176A 1975-10-17 1976-10-08 PROCEDURE FOR THE PREPARATION OF A SOLID SUBSTANCE CONTAINING ONE OR MORE HYDROGENERATED MIDDLE ALCOALOIDS DK146194C (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE2546577 1975-10-17
DE2546577A DE2546577B2 (en) 1975-10-17 1975-10-17 Solid substances made from polyvinylpyrrolidone and ergot alkaloids

Publications (3)

Publication Number Publication Date
DK454176A true DK454176A (en) 1977-04-18
DK146194B DK146194B (en) 1983-07-25
DK146194C DK146194C (en) 1984-01-02

Family

ID=5959411

Family Applications (1)

Application Number Title Priority Date Filing Date
DK454176A DK146194C (en) 1975-10-17 1976-10-08 PROCEDURE FOR THE PREPARATION OF A SOLID SUBSTANCE CONTAINING ONE OR MORE HYDROGENERATED MIDDLE ALCOALOIDS

Country Status (28)

Country Link
JP (1) JPS5854122B2 (en)
AT (1) AT362510B (en)
AU (1) AU508628B2 (en)
BE (1) BE847368A (en)
CA (1) CA1079641A (en)
CH (1) CH643737A5 (en)
CS (1) CS199647B2 (en)
DE (1) DE2546577B2 (en)
DK (1) DK146194C (en)
ES (1) ES452420A1 (en)
FI (1) FI762875A (en)
FR (1) FR2327764A1 (en)
GB (1) GB1560406A (en)
GR (1) GR61268B (en)
HK (1) HK3183A (en)
HU (1) HU172533B (en)
IE (1) IE43778B1 (en)
IL (1) IL50686A (en)
MY (1) MY8400063A (en)
NL (1) NL184558C (en)
NO (1) NO144468C (en)
NZ (1) NZ182341A (en)
PH (1) PH14513A (en)
PT (1) PT65719B (en)
SE (1) SE430379B (en)
SG (1) SG63082G (en)
SU (1) SU1165223A3 (en)
ZA (1) ZA766166B (en)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1572226A (en) * 1977-11-03 1980-07-30 Hoechst Uk Ltd Pharmaceutical preparations in solid unit dosage form
DK154607C (en) * 1978-12-21 1989-06-05 Sandoz Ag PROCEDURE FOR PREPARING A PHARMACEUTICAL FORM FOR ORAL ADMINISTRATION OF ERGOTAL KALOIDS
US4411882A (en) 1978-12-21 1983-10-25 Sandoz Ltd. Galenical compositions
FR2454804B1 (en) * 1979-04-26 1986-11-21 Sanofi Sa DIHYDROERGOTOXIN-BASED MEDICINAL PRODUCT AND PROCESS FOR PREPARING THE SAME
US4366145A (en) * 1981-06-24 1982-12-28 Sandoz, Inc. Soft gelatin capsule with a liquid ergot alkaloid center fill solution and method of preparation
US4898729A (en) * 1983-12-09 1990-02-06 Euroceltique, S.A. Treatment of hypertension, compounds and compositions for antihypertension and diuresis
NL194389C (en) * 1984-06-14 2002-03-04 Novartis Ag Process for preparing a solid dispersion of a pharmaceutically active agent that has low water solubility in a solid matrix of a water-soluble polyalkylene glycol as a carrier.
ATE72111T1 (en) * 1987-01-14 1992-02-15 Ciba Geigy Ag THERAPEUTIC SYSTEM FOR POORLY SOLUBLE ACTIVE INGREDIENTS.
FR2610827B1 (en) * 1987-02-18 1991-09-13 Pf Medicament DIHYDROERGOTAMINE (D.H.E.) TABLET OF THE HYDROPHILIC MATRIX TYPE AND MANUFACTURING METHOD THEREOF
US5064656A (en) * 1989-11-14 1991-11-12 Dr. Gergely & Co. Uncoated pharmaceutical reaction tablet
DE4401646A1 (en) * 1994-01-21 1995-07-27 Krewel Werke Gmbh Optimally releasing kava extracts
US6524832B1 (en) 1994-02-04 2003-02-25 Arch Development Corporation DNA damaging agents in combination with tyrosine kinase inhibitors
MY126580A (en) * 1997-12-22 2006-10-31 Merck Sharp & Dohme Molecular dispersion composition with enchanced bioavailabity
US6632455B2 (en) 1997-12-22 2003-10-14 Schering Corporation Molecular dispersion composition with enhanced bioavailability
US6316462B1 (en) 1999-04-09 2001-11-13 Schering Corporation Methods of inducing cancer cell death and tumor regression
ES2236017T3 (en) * 1999-12-03 2005-07-16 Polichem S.A. PROCEDURES FOR THE PHARMACEUTICAL PREPARATIONS FOR SUSTAINED RELEASE OF ERGOT ALCALOIDS THAT HAVE IMPROVED BIODFISPONIBILITY AND COMPOSITIONS OF THE SAME.
US7771746B2 (en) 1999-12-03 2010-08-10 Polichem Sa Methods for making sustained-release pharmaceutical compositions of ergot alkaloids having improved bioavailability and compositions thereof
US7135436B2 (en) 2003-05-05 2006-11-14 J.F. Daley International, Ltd. Solid algicide, preparation and usage in recirculating water
US20060141038A1 (en) * 2003-06-27 2006-06-29 Bioprogress S. P. A. Composite product obtainable by cogrinding of a active principle with a copolymer n-vinyl-2 pyrrolidone/vinyl-acetate

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1175430A (en) * 1966-04-07 1969-12-23 Sandoz Ltd Pharmaceutical Compositions containing Ergot Alkaloids

Also Published As

Publication number Publication date
DE2546577A1 (en) 1977-04-21
AT362510B (en) 1981-05-25
SE7611189L (en) 1977-04-18
NL184558C (en) 1989-09-01
FR2327764B1 (en) 1979-03-02
AU508628B2 (en) 1980-03-27
SG63082G (en) 1983-09-09
ATA767976A (en) 1980-10-15
HK3183A (en) 1983-01-20
PT65719A (en) 1976-11-01
SE430379B (en) 1983-11-14
NO144468C (en) 1981-09-09
SU1165223A3 (en) 1985-06-30
AU1875476A (en) 1978-04-20
PT65719B (en) 1978-06-12
IL50686A (en) 1979-05-31
JPS5854122B2 (en) 1983-12-02
NZ182341A (en) 1978-09-20
NL7611295A (en) 1977-04-19
FR2327764A1 (en) 1977-05-13
GR61268B (en) 1978-10-17
CS199647B2 (en) 1980-07-31
NL184558B (en) 1989-04-03
CA1079641A (en) 1980-06-17
PH14513A (en) 1981-08-24
MY8400063A (en) 1984-12-31
HU172533B (en) 1978-09-28
DK146194B (en) 1983-07-25
ES452420A1 (en) 1978-04-16
NO144468B (en) 1981-06-01
DE2546577B2 (en) 1981-04-02
IL50686A0 (en) 1976-12-31
CH643737A5 (en) 1984-06-29
GB1560406A (en) 1980-02-06
ZA766166B (en) 1978-05-30
DK146194C (en) 1984-01-02
IE43778B1 (en) 1981-05-20
JPS5251014A (en) 1977-04-23
NO763446L (en) 1977-04-19
FI762875A (en) 1977-04-18
BE847368A (en) 1977-04-15
IE43778L (en) 1977-04-17

Similar Documents

Publication Publication Date Title
ATA971076A (en) ERBICIDE PREPARATIONS
DK256776A (en) ENZYME PREPARATIONS
SE7604607L (en) WIRELINING CONNECTION
FR2302617A1 (en) DI
DK454176A (en) GALENIC PREPARATIONS
DK394176A (en) FUNGICIDE PREPARATIONS
FR2300480A1 (en) DI
DK153811C (en) RODENTICID PREPARATION
FR2300604A1 (en) DI
SE7608478L (en) PHARMACEUTICAL
SE7512782L (en) IMPROVED UROKINAS PREPARATION
JPS51106458A (en) FUTATSUNOTAISHOBUTSUNOAITAIICHIOSOKUTEISHITARI * ARUIHACHOSEISHITARISURUTAMENOSOKUCHOSOCHI
DK143991C (en) combine
BE843053A (en) STUDY
FR2317920A1 (en) ANTHELMINTIC PREPARATIONS
BE853569A (en) MEDICINAL PREPARATIONS
AT353973B (en) COSMETIC INGREDIENT
FR2300972A1 (en) DI
JPS51100054A (en) SHOKUBAISANSAKANJU1 * 55JIMECHIRUTETORARINYORIKAISANSAOJOKYOSURUHOHO
SE7600480L (en) PHARMACEUTICAL USE 2-AMINOACETAMIDO-ALFA-PHENYLBENZYLIDENAMINOALK
JPS51105026A (en) 22AMINOONN * BBHIDORO KISHIIFUENECHIRU ** ASETOAMIDOOJUDOTAINARABINISONOENNOSEIHO
JPS51105331A (en) AZOSENRYO * SONOSEIZOHOHO * OYOBIGOSEIHORIMAAZAIRYOOSENSHOKUSURUHOHO
JPS51110544A (en) EOYOBIFRETSUNOSHINKINO111DEOKISHIICHIKANPUROSUTAGURANJINRUIKAGOBUTSU * SONORASEMIKAGOBUTSU * KYOZOTAIOYOBISONOEN
JPS51102157A (en) TASUNOTAIRANABUTSUTAI * TOKUNITATEITOKANSHIBANOBUNRUISURUTAMENOHOHOOYOBIDOHOHOOJITSUSHISURUTAMENOKEIRETSU
DK142301C (en) combine

Legal Events

Date Code Title Description
PBP Patent lapsed